Procalcitonin in critically ill patients: time to change guidelines and antibiotic use in practice

Affiliations

¹ University of Basel, Medical University Department, Kantonsspital Aarau, Tellstrasse, 5001 Aarau, Switzerland. Electronic address: schuetzph@gmail.com.
² University of Basel, Medical University Department, Kantonsspital Aarau, Tellstrasse, 5001 Aarau, Switzerland.

Comment

Philipp Schuetz et al. Lancet Infect Dis. 2016 Jul.

. 2016 Jul;16(7):758-760.

doi: 10.1016/S1473-3099(16)00064-5. Epub 2016 Mar 2.

¹ University of Basel, Medical University Department, Kantonsspital Aarau, Tellstrasse, 5001 Aarau, Switzerland. Electronic address: schuetzph@gmail.com.
² University of Basel, Medical University Department, Kantonsspital Aarau, Tellstrasse, 5001 Aarau, Switzerland.

No abstract available

Comment on

Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.
de Jong E, van Oers JA, Beishuizen A, Vos P, Vermeijden WJ, Haas LE, Loef BG, Dormans T, van Melsen GC, Kluiters YC, Kemperman H, van den Elsen MJ, Schouten JA, Streefkerk JO, Krabbe HG, Kieft H, Kluge GH, van Dam VC, van Pelt J, Bormans L, Otten MB, Reidinga AC, Endeman H, Twisk JW, van de Garde EMW, de Smet AMGA, Kesecioglu J, Girbes AR, Nijsten MW, de Lange DW. de Jong E, et al. Lancet Infect Dis. 2016 Jul;16(7):819-827. doi: 10.1016/S1473-3099(16)00053-0. Epub 2016 Mar 2. Lancet Infect Dis. 2016. PMID: 26947523 Clinical Trial.